[1]张彬,甄帆,梁斌△.骨水泥分散状态与椎体强化术后残余疼痛的关系[J].中国中医骨伤科杂志,2024,32(04):55-58.[doi:10.20085/j.cnki.issn1005-0205.240411]
　ZHANG Bin,ZHEN Fan,LIANG Bin.Relationship between Bone Cement Dispersion Status and Residual Pain after Vertebral Augmentation[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2024,32(04):55-58.[doi:10.20085/j.cnki.issn1005-0205.240411]
点击复制

骨水泥分散状态与椎体强化术后残余疼痛的关系()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第32卷
期数:
2024年04期
页码:
55-58
栏目:
临床研究
出版日期:
2024-04-01

文章信息/Info

Title:
Relationship between Bone Cement Dispersion Status and Residual Pain after Vertebral Augmentation
文章编号:
1005-0205(2024)04-0055-04
作者:
张彬1; 甄帆1; 梁斌1△
1山西省汾阳医院(山西 汾阳,032200)
Author(s):
ZHANG Bin1; ZHEN Fan1; LIANG Bin1△
1Shanxi Fenyang Hospital,Fenyang 032200,Shanxi China.
关键词:
椎体强化术;  残留疼痛;  骨水泥;  弥散分布
Keywords:
vertebral augmentation;  residual pain;  bone cement;  dispersion distribution
分类号:
R683.2
DOI:
10.20085/j.cnki.issn1005-0205.240411
文献标志码:
A
摘要:
目的:探讨骨水泥分散状态对椎体强化术后残余疼痛的影响及可能的影响因素。方法:回顾性分析2019年5月至2022年4月接受椎体强化术(VA)治疗骨质疏松性椎体压缩骨折(OVCFs)的108例患者。根据骨水泥弥散分布类型,将患者分为高度弥散组(A组)、中度弥散组(B组)和低度弥散组(C组)。对比三组患者视觉模拟量表(VAS)评分、Oswestry功能障碍指数(ODI)评分、损伤椎体高度(IVH)和局部脊柱后凸角度(LKA)的差异。结果:三组患者术后VAS、ODI评分均较术前有明显改善,差异有统计学意义(P<0.05)。末次随访时,A组VAS、ODI评分与B组、C组比较,差异有统计学意义(P<0.05); 且A组优于B组,B组优于C组,差异有统计学意义(P<0.05)。三组患者术后损伤椎体高度和局部脊柱后凸角度均有改善,组间差异无统计学意义(P>0.05)。结论:骨水泥充分分散状态可降低椎体强化术后残余疼痛。
Abstract:
Objective:To investigate the effect of bone cement dispersion on residual pain after vertebral augmentation(VA)and its possible influencing factors.Methods:A retrospective analysis included 108 patients who underwent vertebral augmentation for osteoporotic vertebral compression fractures(OVCFs)between May 2019 and April 2022.Patients were divided into high diffusion group(group A),moderate diffusion group(group B),and low diffusion group(group C)according to the type of bone cement diffusion distribution.Visual analogue scale(VAS),Oswestry disability index(ODI),injured vertebral height(IVH),and local kiphosis angle(LKA)were compared among the three groups.Results:VAS and ODI scores of the three groups were significantly improved compared with those before surgery(P<0.05).At the last follow-up,VAS and ODI scores of group A were significantly different from those of group B and group C(P<0.05),and group A was better than group B and group B was better than group C(P<0.05).IVH and LKA were improved in all three groups,but there was no significant difference between the three groups(P>0.05).Conclusion:Fully dispersed bone cement can reduce residual pain after vertebral augmentation.

参考文献/References:

[1] DING L,WANG H,LI J,et al.Correction:preparation and characterizations of an injectable and biodegradable high-strength iron-bearing brushite cement for bone repair and vertebral augmentation applications[J].Biomater Sci,2023,11(7):2605.
[2] DING Y,LIU J,HAN X,et al.Vertebral augmentation via the rib approach:surgical essentials and therapeutic effects[J].Neurochirurgie,2022,68(4):386-392.
[3] DONG C,ZHU Y,ZHOU J,et al.Therapeutic efficacy of third-generation percutaneous vertebral augmentation system(PVAS)in osteoporotic vertebral compression fractures(OVCFs):a systematic review and meta-analysis[J].Biomed Res Int,2022:9637831.
[4] CABRERA J P,CAMINO-WILLHUBER G,GUIROY A,et al.Vertebral augmentation plus short-segment fixation versus vertebral augmentation alone in Kummell's disease:a systematic review and meta-analysis[J].Neurosurg Rev,2022,45(2):1009-1018.
[5] ABDALLA M A,RODRIGUES R,ULBRICHT C.Vertebral augmentation for painful type 4 osteoporotic compression fractures:a comparative study[J].J Osteoporos,2023:1562892.
[6] BEALL D P,PHILLIPS T R.Vertebral augmentation:an overview[J].Skeletal Radiol,2023,52(10):1911-1920.
[7] PAVLATOS N,KURIAN M,KHAN O,et al.Vertebral augmentation-related clostridium septicum osteomyelitis[J].Radiol Case Rep,2022,17(10):3779-3784.
[8] HOLYOAK D T,ANDRESHAK T G,HOPKINS T J,et al.Height restoration and sustainability using bilateral vertebral augmentation systems for vertebral compression fractures:a cadaveric study[J].Spine J,2022,22(12):2072-2081.
[9] SHARIF S,ALI M Y,COSTA F,et al.Vertebral augmentation in osteoporotic spine fractures:WFNS spine committee recommendations[J].J Neurosurg Sci,2022,66(4):311-326.
[10] ESEONU K C,PANCHMATIA J R,STREETLY M J,et al.The role of vertebral augmentation procedures in the management of vertebral compression fractures secondary to multiple myeloma[J].Hematol Oncol,2023,41(3):323-334.
[11] GE C,CHEN Z,LIN Y,et al.Preoperative prediction of residual back pain after vertebral augmentation for osteoporotic vertebral compression fractures:initial application of a radiomics score based nomogram[J].Front Endocrinol(Lausanne),2022,13:1093508.
[12] GOU P,ZHAO Z,YU C,et al.Efficacy of recombinant human parathyroid hormone versus vertebral augmentation procedure on patients with acute osteoporotic vertebral compression fracture[J].Orthop Surg,2022,14(10):2510-2518.
[13] EHSANIAN R,TO J,KOSHKIN E,et al.A single-center retrospective analysis investigating the effect of timing of vertebral augmentation on pain outcomes[J].Pain Physician,2022,25(9):E1423-E1431.

备注/Memo

备注/Memo:
△通信作者 E-mail:fyyygklb@163.com
更新日期/Last Update: 2024-04-15